Page last updated: 2024-10-26

dimethoate and Multiple Myeloma

dimethoate has been researched along with Multiple Myeloma in 1 studies

Dimethoate: An organothiophosphorus cholinesterase inhibitor that is used as a systemic and contact insecticide.
dimethoate : A monocarboxylic acid amide that is N-methylacetamide in which one of the hydrogens of the methyl group attached to the carbonyl moiety is replaced by a (dimethoxyphosphorothioyl)sulfanediyl group.

Multiple Myeloma: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
KOERTGE, P1

Other Studies

1 other study available for dimethoate and Multiple Myeloma

ArticleYear
[On the therapy of malignant reticuloses with phosphamide esters and corticosteroids].
    Folia haematologica; internationales Magazin fur Blutforschung, 1961, Volume: 6

    Topics: Adrenal Cortex Hormones; Antineoplastic Agents; Cardiovascular Agents; Dimethoate; Esters; Humans; M

1961